SlideShare une entreprise Scribd logo
1  sur  8
Télécharger pour lire hors ligne
Under embargo until 15.00 pm:



Reforming health care, the role of health insurers

Speech by Sean Egan, Chief Executive, Aviva Ireland



Good afternoon ladies and gentlemen.

My name is Sean Egan. I am Chief Executive of Aviva Ireland, which is,
comprised of three separate entities – life and pensions, general insurance,
and of course, health insurance.

Let me start by saying that I am delighted to be afforded the opportunity to
speak with you, to meet you and to listen to you today.

As I came to putting my notes together for my speech today, I was very
conscious of the heavyweight group of very bright and informed minds on
healthcare gathered together in this room.

With this daunting prospect in my mind, I considered what I could bring to
today’s debate.

As CEO of Aviva Ireland, I am tasked with having a broader, longer-term,
development vision for our business, including planning for the future
growth of our healthcare business.

Without this oversight function, it is all too easy to get bogged down in the
intricacies of our complex health care system and health insurance
provision, without ever addressing the wider, macro challenges which are
prevalent in that system.

So in terms of my contribution today, I hope that I can give you a brief,
summary of Aviva’s vision for the future of private health insurance in
Ireland.

Health insurers are in an unusual position in the overall health system.

We are not health care service providers; we are not the end users; nor, are
we health policy decision-makers.
Yet we are at front and centre in the lives of those for whom the whole
health system exists in the first instance – patients.

We facilitate patients, our customers, in gaining access to the treatments
and services which they require. We do this by acting effectively as the
middle man between the health service and the patient.

Every decision which is taken in the provision of healthcare affects our
customers and by extension our business model in a significant way.

Talking about our healthcare system and business in the same sentence has
the potential to make many people uncomfortable. However, given the
structure of our healthcare system, it is vital that the two are fully synched.

Of course there are increased sensitivities around healthcare. It is so
personal and of vital importance to each of us, our families and our
communities.

Healthcare cannot and should never be treated like any other business.

Yet healthcare can learn much from business.

The challenge, for the private and public sectors alike, is to get the balance
right between providing customers with the highest levels of service and
customer care, while keeping a constant eye on your costs and the wider
operating environment.

The health insurance sector, like all sectors, is experiencing real challenges.

47% of the Irish population now have private insurance. This figure has
been in decline since 2008. In 2011, 66,000 people dropped out of private
health insurance market. Others have been forced to trade down or reduce
their level of cover.

This is happening against the backdrop of a severe economic downturn;
high unemployment levels; and, rising premium prices.

The declining numbers is a major cause of concern for the health insurance
sector and also, I imagine, for the Minister and the HSE because of its
knock-on impact on public health services.
Despite this bleak backdrop, we can be positive about the private health
insurance sector and its long-term future.

Almost half of our population continue to be covered by private health
insurance.

Equally, people remain reluctant to abandon private health insurance. This
gives me confidence that once economic recovery takes hold, the numbers
participating in health insurance will bounce back again.

My expectation of a renewed uptake in private health insurance in an
improved economy comes with one major caveat.

It will not happen unless we have a fundamental reform of the health
insurance market.

We particularly need to address:

    How can private health insurance help the Government deliver on its
     vision for healthcare in Ireland?

    How private health insurance delivers for its customers?

    How private health insurance operates in terms of the market
     structure and regulation.

Without reform, we will not have the well-functioning and competitive
health insurance market necessary to fund our health service.

The introduction of Universal Health Insurance (UHI) will mark a
significant shift in our current system of healthcare provision, particularly
how the system is funded.

Aviva Health Insurance is fully supportive of UHI.

Indeed, Aviva globally has had a positive experience of UHI in other
countries including the Netherlands. Given Aviva’s global experience of
working in different healthcare systems, we hope to use this experience to
contribute to UHI’s introduction.

UHI will lead to a fairer allocation of health resources in the health system
and enable patients to gain access to treatment based on need, rather than
ability to pay.
UHI, while a worthy initiative, is just one part of the reform package.

UHI will bring a new funding model, but it will not address the structural
and institutional defects in the health service.

Indeed, if UHI is to succeed, it is vital that these defects are removed.

That includes addressing issues like waiting lists which Dr. Martin Connor
from the special delivery unit is tackling, increased primary care and of
course, an issue close to Aviva’s heart, reform of the health insurance
market.

The introduction of UHI will be a huge challenge for all within our health
system.

I cannot claim to be an expert on UHI, but I can speak about my personal
experience of managing significant organisation transformation projects.

This gives me some understanding of the complexities which lie ahead for
Minister Reilly. I do not envy his task.

I sense too that it is starting to crystallise in the minds of decision makers
that for UHI to work, the role of health insurers will be key.

If anything under UHI, private health insurance’s importance will grow.

The contribution of private sector health insurance will be vital to support
the State subsidised element of UHI.

Central to UHI’s success will be:

    A long-term sustainable health insurance market with patients at its
     core;

    Underpinned by robust competition between insurers and between
     health care providers;

    Providing affordable health insurance for all regardless of their
     income, risk profile or other criteria.
The key issue for our customers and for health insurers remains
affordability. It is the single most important issue facing customers and the
industry and will remain so, even with UHI.

The affordability of private health insurance, most evident from the rising
cost of insurance premiums, has been undermined in recent years.

Medical inflation; a failure to contain costs; failure to reform both
healthcare provision and health insurance; lack of competition in the health
insurance market and the introduction of Government levies, have all
undermined affordability.

Two matters in particular are critical issues when it comes to affordability
and the long-term sustainability of the private health insurance market.

The first of these is the recent proposal to re-designate existing private
beds in public hospitals.

This proposal will see charges levied against private patients in public
hospitals. Private patients will now be paying for a bed in a public hospital
on the double – through their taxes and through their private health
insurance.

It is a retrograde step which will further undermine the affordability of
private health insurance, increase costs to private patients and push up
premiums.

We talk much about fair and equitable access to health care, yet if this
proposal proceeds we are abandoning both.

Private patients will migrate to private hospitals and public hospitals will
lose out on the millions of euro in funding they currently collect from
privately insured patients.

No one wins.

As things stand, this proposal is exactly that – a proposal. It requires
further thought. The Health Insurance Consultative Forum, recently
established by Minister Reilly, is an ideal environment to give this proposal
deeper evaluation.
The proposal on bed re-designation comes against a wider backdrop of
rising bed charges over the past number of years.

One way to contain bed charge increases is to allow insurers negotiate bed
charges with individual hospitals. Currently, the Minister applies a one-
size-fits-all charge.

The Minister has publicly called on insurers to control premium increases
by negotiating prices with the service providers, whether hospitals or
consultants. Allowing insurers negotiate with hospitals empowers us to do
this. It is something which Aviva fully supports.

The second factor hindering affordability is health insurance competition.

We need to do more to make our health insurance market more
competitive. To do that, we need radical reform.

The Minister for Health and the Minister for Finance – who also has a key
role in this area – have given positive indications around reform.

Aviva welcomed the decision by the Minister for Health to establish a
Health Insurance Consultative Forum to drive this programme.

But no Forums are necessary to highlight the one glaring inequity which
exists in health insurance today – regulation, or the lack of regulation.

Currently, the dominant player in the market, Vhi, with almost 60% of the
total market, remains unregulated by the Central Bank of Ireland.

The failure to regulate the Vhi perpetuates a situation where Vhi is treated
in a different and more favourable manner from its competitors.

The result of this lack of regulation is two-fold:

    It leaves Vhi in a protected position and impedes the development of
     a truly competitive health insurance market; and

    The Vhi continues to be exempt from the Consumer Protection Code
     (CPC), imposed by the Central Bank of Ireland and designed to
     protect consumers. This may leave consumers vulnerable in their
     dealings with Vhi.
I mentioned the Code because as many of you may know, Aviva, itself, was
recently fined by the Central Bank for breaches of this Code.

We regret that this breach happened in the first instance. Once aware of it,
we took immediate steps to rectify these breaches, a fact which was
acknowledged by the CBI in reaching a settlement.

I make no bones about it.

Aviva Health implemented the Code in full but failed to abide to the letter of
the Code.

Fortunately, no customers were disadvantaged by the breach, nonetheless,
we recognise that the Code requires complete adherence.

Given Ireland’s financial recent history, it is understandable that the CBI
takes the need for regulation seriously.

The result of our breach was that we were slapped on the wrist to the tune
of almost €250,000.

Believe me it is a painful slap for any company.

We accept the Central Bank’s rationale. But if that rationale is being applied
to some and not all, then the whole system is undermined.

All players in the market must be subject to a level playing field and a
regulatory regime which treats all equally.

With the Vhi outside of regulation, this is not currently the case. It is
hindering a truly competitive market.

To be fair, Vhi is working to streamline its operations and its annual results
published yesterday reflect this.

However, in terms of its regulation the power to act lies with Ministers for
Finance and Health.

In the short term, the need for the Government to increase the Vhi’s capital
solvency margins and the costs to the Exchequer of doing so, impede
regulation. However, Ireland’s current budgetary constraints cannot be
used as an excuse.
Aviva believes that the Government and Central Bank can decouple the
solvency issue from CPC regulation by seeking to resolve the solvency issue
in the medium term and applying the Consumer Protection Code to Vhi in
the immediate term.

In conclusion, let me leave you with some positive comments.

In my experience, properly run private health insurers are extremely adept
at managing costs. This feeds directly into the wider healthcare system.
Effective cost control with a focus on primary care will help make
healthcare more accessible and affordable for all.

Private health insurers are also often first adopters of new technology and
medical innovations.

For example, drawing from Aviva’s own experiences, we were the first, and
only, health insurer to cover our customers with breast cancer, for
Oncotype DX testing, on all health insurance plans.

This breakthrough test is now also being provided by the State. It has the
potential to transform clinical cancer care and could help women
diagnosed with breast cancer avoid unnecessary chemotherapy, saving
patients from unnecessary treatment and the government unnecessary
costs.

Similarly, Aviva Health was also the first to offer discounted cervical cancer
vaccinations under our health plans. This initiative was followed by a
universal vaccination programme.

I am convinced that private health insurers have the capacity to continue to
be first responders to healthcare innovations which deliver cost savings
and benefits for patients.

I am convinced that private health insurers have a vital role to play in the
reform agenda.

And I am convinced more than ever that our input will result in better
policy decisions, better outcomes for patients and a better, more viable
healthcare system.

Thank you.

Contenu connexe

Tendances

Health insurance in India- Dr Suraj Chawla
Health insurance in India- Dr Suraj ChawlaHealth insurance in India- Dr Suraj Chawla
Health insurance in India- Dr Suraj ChawlaSuraj Chawla
 
September welfare benefits
September welfare benefitsSeptember welfare benefits
September welfare benefitskatymcgrory
 
Ccd comments on patient protection regulations
Ccd comments on patient protection regulationsCcd comments on patient protection regulations
Ccd comments on patient protection regulationsThe National Council
 
The Impact of Health Care Legislation on Staffing
The Impact of Health Care Legislation on StaffingThe Impact of Health Care Legislation on Staffing
The Impact of Health Care Legislation on StaffingAaron Lesher
 
Steps to follow to buy best health insurance in india
Steps to follow to buy best health insurance in indiaSteps to follow to buy best health insurance in india
Steps to follow to buy best health insurance in indiaCoverfox-Insurance
 
Uhi presentation oct 2012
Uhi presentation oct 2012Uhi presentation oct 2012
Uhi presentation oct 2012Oliver O'Connor
 
Health insurance pages 1 81
Health insurance pages 1 81Health insurance pages 1 81
Health insurance pages 1 81Dharmik
 
UNEP-PSI webinar series "Making inclusive insurance work" - session 6: Health...
UNEP-PSI webinar series "Making inclusive insurance work" - session 6: Health...UNEP-PSI webinar series "Making inclusive insurance work" - session 6: Health...
UNEP-PSI webinar series "Making inclusive insurance work" - session 6: Health...Impact Insurance Facility
 
Got Healthcare? The Affordable Care Act 2012 w/ Video
Got Healthcare? The Affordable Care Act 2012 w/ VideoGot Healthcare? The Affordable Care Act 2012 w/ Video
Got Healthcare? The Affordable Care Act 2012 w/ VideoKevin Kane
 
Rashtriya swasthya bima yojna- RSBY
Rashtriya swasthya bima yojna- RSBY Rashtriya swasthya bima yojna- RSBY
Rashtriya swasthya bima yojna- RSBY Megha Ahuja
 
Walkercare vs Obamacare: Which Do You Choose?
Walkercare vs Obamacare: Which Do You Choose?Walkercare vs Obamacare: Which Do You Choose?
Walkercare vs Obamacare: Which Do You Choose?Kevin Kane
 
India Health Insurance Scenario - September 2012
India Health Insurance Scenario - September 2012India Health Insurance Scenario - September 2012
India Health Insurance Scenario - September 2012Sudip Mukhopadhyay
 
Wall of Protection: Health, Income, and Life Insurance
Wall of Protection: Health, Income, and Life InsuranceWall of Protection: Health, Income, and Life Insurance
Wall of Protection: Health, Income, and Life InsuranceAlanna Russell
 

Tendances (20)

Health insurance in India- Dr Suraj Chawla
Health insurance in India- Dr Suraj ChawlaHealth insurance in India- Dr Suraj Chawla
Health insurance in India- Dr Suraj Chawla
 
September welfare benefits
September welfare benefitsSeptember welfare benefits
September welfare benefits
 
Ccd comments on patient protection regulations
Ccd comments on patient protection regulationsCcd comments on patient protection regulations
Ccd comments on patient protection regulations
 
Healthcare insurance products
Healthcare insurance products   Healthcare insurance products
Healthcare insurance products
 
The Impact of Health Care Legislation on Staffing
The Impact of Health Care Legislation on StaffingThe Impact of Health Care Legislation on Staffing
The Impact of Health Care Legislation on Staffing
 
Steps to follow to buy best health insurance in india
Steps to follow to buy best health insurance in indiaSteps to follow to buy best health insurance in india
Steps to follow to buy best health insurance in india
 
Uhi presentation oct 2012
Uhi presentation oct 2012Uhi presentation oct 2012
Uhi presentation oct 2012
 
Rashtriya Swasthya Bima Yojana
Rashtriya Swasthya Bima Yojana Rashtriya Swasthya Bima Yojana
Rashtriya Swasthya Bima Yojana
 
Health insurance pages 1 81
Health insurance pages 1 81Health insurance pages 1 81
Health insurance pages 1 81
 
UNEP-PSI webinar series "Making inclusive insurance work" - session 6: Health...
UNEP-PSI webinar series "Making inclusive insurance work" - session 6: Health...UNEP-PSI webinar series "Making inclusive insurance work" - session 6: Health...
UNEP-PSI webinar series "Making inclusive insurance work" - session 6: Health...
 
Health insurence
Health insurenceHealth insurence
Health insurence
 
Got Healthcare? The Affordable Care Act 2012 w/ Video
Got Healthcare? The Affordable Care Act 2012 w/ VideoGot Healthcare? The Affordable Care Act 2012 w/ Video
Got Healthcare? The Affordable Care Act 2012 w/ Video
 
Rashtriya swasthya bima yojna- RSBY
Rashtriya swasthya bima yojna- RSBY Rashtriya swasthya bima yojna- RSBY
Rashtriya swasthya bima yojna- RSBY
 
Continuum_Fall-2015
Continuum_Fall-2015Continuum_Fall-2015
Continuum_Fall-2015
 
Walkercare vs Obamacare: Which Do You Choose?
Walkercare vs Obamacare: Which Do You Choose?Walkercare vs Obamacare: Which Do You Choose?
Walkercare vs Obamacare: Which Do You Choose?
 
UCR
UCRUCR
UCR
 
India Health Insurance Scenario - September 2012
India Health Insurance Scenario - September 2012India Health Insurance Scenario - September 2012
India Health Insurance Scenario - September 2012
 
Wall of Protection: Health, Income, and Life Insurance
Wall of Protection: Health, Income, and Life InsuranceWall of Protection: Health, Income, and Life Insurance
Wall of Protection: Health, Income, and Life Insurance
 
Health Insurance
Health InsuranceHealth Insurance
Health Insurance
 
10. health ins.
10. health ins.10. health ins.
10. health ins.
 

En vedette

EvolucióN Sobre Los Adhesivosvv
EvolucióN Sobre Los AdhesivosvvEvolucióN Sobre Los Adhesivosvv
EvolucióN Sobre Los Adhesivosvvguest95f6b0
 
Klimaatverandering Update 2007
Klimaatverandering Update 2007Klimaatverandering Update 2007
Klimaatverandering Update 2007GreenFacts
 
Aimee Madden, MD Perofrmation, Ireland & UK
Aimee Madden, MD Perofrmation, Ireland & UKAimee Madden, MD Perofrmation, Ireland & UK
Aimee Madden, MD Perofrmation, Ireland & UKInvestnet
 
Oliver o'connor health insurance 24 march
Oliver o'connor health insurance 24 marchOliver o'connor health insurance 24 march
Oliver o'connor health insurance 24 marchInvestnet
 
Whitepaper 4 20-fn%5_b2%5d
Whitepaper 4 20-fn%5_b2%5dWhitepaper 4 20-fn%5_b2%5d
Whitepaper 4 20-fn%5_b2%5dPROmanager
 
Dr. Douglas Rosendale
Dr. Douglas Rosendale Dr. Douglas Rosendale
Dr. Douglas Rosendale Investnet
 

En vedette (7)

EvolucióN Sobre Los Adhesivosvv
EvolucióN Sobre Los AdhesivosvvEvolucióN Sobre Los Adhesivosvv
EvolucióN Sobre Los Adhesivosvv
 
manualidades
manualidadesmanualidades
manualidades
 
Klimaatverandering Update 2007
Klimaatverandering Update 2007Klimaatverandering Update 2007
Klimaatverandering Update 2007
 
Aimee Madden, MD Perofrmation, Ireland & UK
Aimee Madden, MD Perofrmation, Ireland & UKAimee Madden, MD Perofrmation, Ireland & UK
Aimee Madden, MD Perofrmation, Ireland & UK
 
Oliver o'connor health insurance 24 march
Oliver o'connor health insurance 24 marchOliver o'connor health insurance 24 march
Oliver o'connor health insurance 24 march
 
Whitepaper 4 20-fn%5_b2%5d
Whitepaper 4 20-fn%5_b2%5dWhitepaper 4 20-fn%5_b2%5d
Whitepaper 4 20-fn%5_b2%5d
 
Dr. Douglas Rosendale
Dr. Douglas Rosendale Dr. Douglas Rosendale
Dr. Douglas Rosendale
 

Similaire à Sean Egan, Aviva

August Newsletter
August NewsletterAugust Newsletter
August Newslettermikewojcik
 
Newsletter Discussing Debt
Newsletter Discussing DebtNewsletter Discussing Debt
Newsletter Discussing DebtThe Horton Group
 
Newsletter Discussing Debt
Newsletter Discussing DebtNewsletter Discussing Debt
Newsletter Discussing DebtThe Horton Group
 
mHealth Israel_Consumer centric healthcare 2015_william blair
mHealth Israel_Consumer centric healthcare 2015_william blairmHealth Israel_Consumer centric healthcare 2015_william blair
mHealth Israel_Consumer centric healthcare 2015_william blairLevi Shapiro
 
Nhi and medical schemes amendment bill announcement minister's speech
Nhi and medical schemes amendment bill announcement  minister's speechNhi and medical schemes amendment bill announcement  minister's speech
Nhi and medical schemes amendment bill announcement minister's speechSABC News
 
hCentive Health Insurance Exchange Platform
hCentive Health Insurance Exchange PlatformhCentive Health Insurance Exchange Platform
hCentive Health Insurance Exchange PlatformAlisha North
 
Dr13 the future_of_health_care_insurance_whats_ahead3
Dr13 the future_of_health_care_insurance_whats_ahead3Dr13 the future_of_health_care_insurance_whats_ahead3
Dr13 the future_of_health_care_insurance_whats_ahead3Ariel Porath
 
Preliminary Risk Assessment on WellPoint
Preliminary Risk Assessment on WellPointPreliminary Risk Assessment on WellPoint
Preliminary Risk Assessment on WellPointBrittany Shephard
 
ABI Welfare Reform report 2014
ABI Welfare Reform report 2014ABI Welfare Reform report 2014
ABI Welfare Reform report 2014Helen White
 
Designing Ideal Health Insurance
Designing Ideal Health InsuranceDesigning Ideal Health Insurance
Designing Ideal Health Insurancephilhickmon
 
Health insurance and Labor Market in Bangladesh (Animated)
Health insurance and Labor Market in Bangladesh (Animated)Health insurance and Labor Market in Bangladesh (Animated)
Health insurance and Labor Market in Bangladesh (Animated)Fahmida Ankhi
 
HealthcareRountable_SFV_20150810
HealthcareRountable_SFV_20150810HealthcareRountable_SFV_20150810
HealthcareRountable_SFV_20150810Danone Simpson
 
Nada presentation hi1 a
Nada presentation hi1 aNada presentation hi1 a
Nada presentation hi1 aNada A
 
1Running Head CRITICAL THINKING NEW HOSPITAL PROPOSALCR.docx
1Running Head CRITICAL THINKING NEW HOSPITAL PROPOSALCR.docx1Running Head CRITICAL THINKING NEW HOSPITAL PROPOSALCR.docx
1Running Head CRITICAL THINKING NEW HOSPITAL PROPOSALCR.docxfelicidaddinwoodie
 

Similaire à Sean Egan, Aviva (17)

August Newsletter
August NewsletterAugust Newsletter
August Newsletter
 
Essays On Health Care
Essays On Health CareEssays On Health Care
Essays On Health Care
 
Newsletter Discussing Debt
Newsletter Discussing DebtNewsletter Discussing Debt
Newsletter Discussing Debt
 
Newsletter Discussing Debt
Newsletter Discussing DebtNewsletter Discussing Debt
Newsletter Discussing Debt
 
A health insurance roadmap
A health insurance roadmapA health insurance roadmap
A health insurance roadmap
 
FICCI_Leapfrogging
FICCI_LeapfroggingFICCI_Leapfrogging
FICCI_Leapfrogging
 
mHealth Israel_Consumer centric healthcare 2015_william blair
mHealth Israel_Consumer centric healthcare 2015_william blairmHealth Israel_Consumer centric healthcare 2015_william blair
mHealth Israel_Consumer centric healthcare 2015_william blair
 
Nhi and medical schemes amendment bill announcement minister's speech
Nhi and medical schemes amendment bill announcement  minister's speechNhi and medical schemes amendment bill announcement  minister's speech
Nhi and medical schemes amendment bill announcement minister's speech
 
hCentive Health Insurance Exchange Platform
hCentive Health Insurance Exchange PlatformhCentive Health Insurance Exchange Platform
hCentive Health Insurance Exchange Platform
 
Dr13 the future_of_health_care_insurance_whats_ahead3
Dr13 the future_of_health_care_insurance_whats_ahead3Dr13 the future_of_health_care_insurance_whats_ahead3
Dr13 the future_of_health_care_insurance_whats_ahead3
 
Preliminary Risk Assessment on WellPoint
Preliminary Risk Assessment on WellPointPreliminary Risk Assessment on WellPoint
Preliminary Risk Assessment on WellPoint
 
ABI Welfare Reform report 2014
ABI Welfare Reform report 2014ABI Welfare Reform report 2014
ABI Welfare Reform report 2014
 
Designing Ideal Health Insurance
Designing Ideal Health InsuranceDesigning Ideal Health Insurance
Designing Ideal Health Insurance
 
Health insurance and Labor Market in Bangladesh (Animated)
Health insurance and Labor Market in Bangladesh (Animated)Health insurance and Labor Market in Bangladesh (Animated)
Health insurance and Labor Market in Bangladesh (Animated)
 
HealthcareRountable_SFV_20150810
HealthcareRountable_SFV_20150810HealthcareRountable_SFV_20150810
HealthcareRountable_SFV_20150810
 
Nada presentation hi1 a
Nada presentation hi1 aNada presentation hi1 a
Nada presentation hi1 a
 
1Running Head CRITICAL THINKING NEW HOSPITAL PROPOSALCR.docx
1Running Head CRITICAL THINKING NEW HOSPITAL PROPOSALCR.docx1Running Head CRITICAL THINKING NEW HOSPITAL PROPOSALCR.docx
1Running Head CRITICAL THINKING NEW HOSPITAL PROPOSALCR.docx
 

Plus de Investnet

Grainne Flynn , Blood Sugar Trampoline:Patient Speaker
Grainne Flynn , Blood Sugar Trampoline:Patient SpeakerGrainne Flynn , Blood Sugar Trampoline:Patient Speaker
Grainne Flynn , Blood Sugar Trampoline:Patient SpeakerInvestnet
 
Dr Neil Black , Consultant Physician
Dr Neil Black , Consultant PhysicianDr Neil Black , Consultant Physician
Dr Neil Black , Consultant PhysicianInvestnet
 
Gerald Tomkin , Director of the Diabetes Institute Beacon Hospital
Gerald Tomkin , Director of the Diabetes Institute Beacon HospitalGerald Tomkin , Director of the Diabetes Institute Beacon Hospital
Gerald Tomkin , Director of the Diabetes Institute Beacon HospitalInvestnet
 
Dr. Ronan Canavan , Clinical lead of the National Clinical Programme for Diab...
Dr. Ronan Canavan , Clinical lead of the National Clinical Programme for Diab...Dr. Ronan Canavan , Clinical lead of the National Clinical Programme for Diab...
Dr. Ronan Canavan , Clinical lead of the National Clinical Programme for Diab...Investnet
 
Healthbridge
HealthbridgeHealthbridge
HealthbridgeInvestnet
 
Think Biosolution
Think BiosolutionThink Biosolution
Think BiosolutionInvestnet
 
Malcolm R. Kell, Breast Cancer Survivor
Malcolm R. Kell, Breast Cancer SurvivorMalcolm R. Kell, Breast Cancer Survivor
Malcolm R. Kell, Breast Cancer SurvivorInvestnet
 
Control Drink
Control DrinkControl Drink
Control DrinkInvestnet
 
Robert Kelly, Videodoc
Robert Kelly, VideodocRobert Kelly, Videodoc
Robert Kelly, VideodocInvestnet
 
Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...
Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...
Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...Investnet
 
Anastasia Dedyukhina , Consciously Digital
Anastasia Dedyukhina , Consciously DigitalAnastasia Dedyukhina , Consciously Digital
Anastasia Dedyukhina , Consciously DigitalInvestnet
 
Sasha Oliver, Avloni
Sasha Oliver, AvloniSasha Oliver, Avloni
Sasha Oliver, AvloniInvestnet
 
Jemma Gatliff, Keregen
Jemma Gatliff, KeregenJemma Gatliff, Keregen
Jemma Gatliff, KeregenInvestnet
 
Darren Cunningham, Inflection Bio Sciences
Darren Cunningham, Inflection Bio SciencesDarren Cunningham, Inflection Bio Sciences
Darren Cunningham, Inflection Bio SciencesInvestnet
 
Phision Theraputics
Phision TheraputicsPhision Theraputics
Phision TheraputicsInvestnet
 
Niamh Malone , Brainey App
Niamh Malone , Brainey App Niamh Malone , Brainey App
Niamh Malone , Brainey App Investnet
 
Toby Basey-Fisher , CEO, Co Founder, Eva Diagnostics
Toby Basey-Fisher , CEO, Co Founder, Eva DiagnosticsToby Basey-Fisher , CEO, Co Founder, Eva Diagnostics
Toby Basey-Fisher , CEO, Co Founder, Eva DiagnosticsInvestnet
 
Ena Prosser, Fountain Healthcare Partners
Ena Prosser, Fountain Healthcare PartnersEna Prosser, Fountain Healthcare Partners
Ena Prosser, Fountain Healthcare PartnersInvestnet
 
Cathal Friel, Raglan Capital
Cathal Friel, Raglan CapitalCathal Friel, Raglan Capital
Cathal Friel, Raglan CapitalInvestnet
 
Kieran O’Connell , DIT Hothouse
Kieran O’Connell , DIT HothouseKieran O’Connell , DIT Hothouse
Kieran O’Connell , DIT HothouseInvestnet
 

Plus de Investnet (20)

Grainne Flynn , Blood Sugar Trampoline:Patient Speaker
Grainne Flynn , Blood Sugar Trampoline:Patient SpeakerGrainne Flynn , Blood Sugar Trampoline:Patient Speaker
Grainne Flynn , Blood Sugar Trampoline:Patient Speaker
 
Dr Neil Black , Consultant Physician
Dr Neil Black , Consultant PhysicianDr Neil Black , Consultant Physician
Dr Neil Black , Consultant Physician
 
Gerald Tomkin , Director of the Diabetes Institute Beacon Hospital
Gerald Tomkin , Director of the Diabetes Institute Beacon HospitalGerald Tomkin , Director of the Diabetes Institute Beacon Hospital
Gerald Tomkin , Director of the Diabetes Institute Beacon Hospital
 
Dr. Ronan Canavan , Clinical lead of the National Clinical Programme for Diab...
Dr. Ronan Canavan , Clinical lead of the National Clinical Programme for Diab...Dr. Ronan Canavan , Clinical lead of the National Clinical Programme for Diab...
Dr. Ronan Canavan , Clinical lead of the National Clinical Programme for Diab...
 
Healthbridge
HealthbridgeHealthbridge
Healthbridge
 
Think Biosolution
Think BiosolutionThink Biosolution
Think Biosolution
 
Malcolm R. Kell, Breast Cancer Survivor
Malcolm R. Kell, Breast Cancer SurvivorMalcolm R. Kell, Breast Cancer Survivor
Malcolm R. Kell, Breast Cancer Survivor
 
Control Drink
Control DrinkControl Drink
Control Drink
 
Robert Kelly, Videodoc
Robert Kelly, VideodocRobert Kelly, Videodoc
Robert Kelly, Videodoc
 
Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...
Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...
Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...
 
Anastasia Dedyukhina , Consciously Digital
Anastasia Dedyukhina , Consciously DigitalAnastasia Dedyukhina , Consciously Digital
Anastasia Dedyukhina , Consciously Digital
 
Sasha Oliver, Avloni
Sasha Oliver, AvloniSasha Oliver, Avloni
Sasha Oliver, Avloni
 
Jemma Gatliff, Keregen
Jemma Gatliff, KeregenJemma Gatliff, Keregen
Jemma Gatliff, Keregen
 
Darren Cunningham, Inflection Bio Sciences
Darren Cunningham, Inflection Bio SciencesDarren Cunningham, Inflection Bio Sciences
Darren Cunningham, Inflection Bio Sciences
 
Phision Theraputics
Phision TheraputicsPhision Theraputics
Phision Theraputics
 
Niamh Malone , Brainey App
Niamh Malone , Brainey App Niamh Malone , Brainey App
Niamh Malone , Brainey App
 
Toby Basey-Fisher , CEO, Co Founder, Eva Diagnostics
Toby Basey-Fisher , CEO, Co Founder, Eva DiagnosticsToby Basey-Fisher , CEO, Co Founder, Eva Diagnostics
Toby Basey-Fisher , CEO, Co Founder, Eva Diagnostics
 
Ena Prosser, Fountain Healthcare Partners
Ena Prosser, Fountain Healthcare PartnersEna Prosser, Fountain Healthcare Partners
Ena Prosser, Fountain Healthcare Partners
 
Cathal Friel, Raglan Capital
Cathal Friel, Raglan CapitalCathal Friel, Raglan Capital
Cathal Friel, Raglan Capital
 
Kieran O’Connell , DIT Hothouse
Kieran O’Connell , DIT HothouseKieran O’Connell , DIT Hothouse
Kieran O’Connell , DIT Hothouse
 

Dernier

Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptMumux Mirani
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalityhardikdabas3
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 

Dernier (20)

Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.ppt
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortality
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 

Sean Egan, Aviva

  • 1. Under embargo until 15.00 pm: Reforming health care, the role of health insurers Speech by Sean Egan, Chief Executive, Aviva Ireland Good afternoon ladies and gentlemen. My name is Sean Egan. I am Chief Executive of Aviva Ireland, which is, comprised of three separate entities – life and pensions, general insurance, and of course, health insurance. Let me start by saying that I am delighted to be afforded the opportunity to speak with you, to meet you and to listen to you today. As I came to putting my notes together for my speech today, I was very conscious of the heavyweight group of very bright and informed minds on healthcare gathered together in this room. With this daunting prospect in my mind, I considered what I could bring to today’s debate. As CEO of Aviva Ireland, I am tasked with having a broader, longer-term, development vision for our business, including planning for the future growth of our healthcare business. Without this oversight function, it is all too easy to get bogged down in the intricacies of our complex health care system and health insurance provision, without ever addressing the wider, macro challenges which are prevalent in that system. So in terms of my contribution today, I hope that I can give you a brief, summary of Aviva’s vision for the future of private health insurance in Ireland. Health insurers are in an unusual position in the overall health system. We are not health care service providers; we are not the end users; nor, are we health policy decision-makers.
  • 2. Yet we are at front and centre in the lives of those for whom the whole health system exists in the first instance – patients. We facilitate patients, our customers, in gaining access to the treatments and services which they require. We do this by acting effectively as the middle man between the health service and the patient. Every decision which is taken in the provision of healthcare affects our customers and by extension our business model in a significant way. Talking about our healthcare system and business in the same sentence has the potential to make many people uncomfortable. However, given the structure of our healthcare system, it is vital that the two are fully synched. Of course there are increased sensitivities around healthcare. It is so personal and of vital importance to each of us, our families and our communities. Healthcare cannot and should never be treated like any other business. Yet healthcare can learn much from business. The challenge, for the private and public sectors alike, is to get the balance right between providing customers with the highest levels of service and customer care, while keeping a constant eye on your costs and the wider operating environment. The health insurance sector, like all sectors, is experiencing real challenges. 47% of the Irish population now have private insurance. This figure has been in decline since 2008. In 2011, 66,000 people dropped out of private health insurance market. Others have been forced to trade down or reduce their level of cover. This is happening against the backdrop of a severe economic downturn; high unemployment levels; and, rising premium prices. The declining numbers is a major cause of concern for the health insurance sector and also, I imagine, for the Minister and the HSE because of its knock-on impact on public health services.
  • 3. Despite this bleak backdrop, we can be positive about the private health insurance sector and its long-term future. Almost half of our population continue to be covered by private health insurance. Equally, people remain reluctant to abandon private health insurance. This gives me confidence that once economic recovery takes hold, the numbers participating in health insurance will bounce back again. My expectation of a renewed uptake in private health insurance in an improved economy comes with one major caveat. It will not happen unless we have a fundamental reform of the health insurance market. We particularly need to address:  How can private health insurance help the Government deliver on its vision for healthcare in Ireland?  How private health insurance delivers for its customers?  How private health insurance operates in terms of the market structure and regulation. Without reform, we will not have the well-functioning and competitive health insurance market necessary to fund our health service. The introduction of Universal Health Insurance (UHI) will mark a significant shift in our current system of healthcare provision, particularly how the system is funded. Aviva Health Insurance is fully supportive of UHI. Indeed, Aviva globally has had a positive experience of UHI in other countries including the Netherlands. Given Aviva’s global experience of working in different healthcare systems, we hope to use this experience to contribute to UHI’s introduction. UHI will lead to a fairer allocation of health resources in the health system and enable patients to gain access to treatment based on need, rather than ability to pay.
  • 4. UHI, while a worthy initiative, is just one part of the reform package. UHI will bring a new funding model, but it will not address the structural and institutional defects in the health service. Indeed, if UHI is to succeed, it is vital that these defects are removed. That includes addressing issues like waiting lists which Dr. Martin Connor from the special delivery unit is tackling, increased primary care and of course, an issue close to Aviva’s heart, reform of the health insurance market. The introduction of UHI will be a huge challenge for all within our health system. I cannot claim to be an expert on UHI, but I can speak about my personal experience of managing significant organisation transformation projects. This gives me some understanding of the complexities which lie ahead for Minister Reilly. I do not envy his task. I sense too that it is starting to crystallise in the minds of decision makers that for UHI to work, the role of health insurers will be key. If anything under UHI, private health insurance’s importance will grow. The contribution of private sector health insurance will be vital to support the State subsidised element of UHI. Central to UHI’s success will be:  A long-term sustainable health insurance market with patients at its core;  Underpinned by robust competition between insurers and between health care providers;  Providing affordable health insurance for all regardless of their income, risk profile or other criteria.
  • 5. The key issue for our customers and for health insurers remains affordability. It is the single most important issue facing customers and the industry and will remain so, even with UHI. The affordability of private health insurance, most evident from the rising cost of insurance premiums, has been undermined in recent years. Medical inflation; a failure to contain costs; failure to reform both healthcare provision and health insurance; lack of competition in the health insurance market and the introduction of Government levies, have all undermined affordability. Two matters in particular are critical issues when it comes to affordability and the long-term sustainability of the private health insurance market. The first of these is the recent proposal to re-designate existing private beds in public hospitals. This proposal will see charges levied against private patients in public hospitals. Private patients will now be paying for a bed in a public hospital on the double – through their taxes and through their private health insurance. It is a retrograde step which will further undermine the affordability of private health insurance, increase costs to private patients and push up premiums. We talk much about fair and equitable access to health care, yet if this proposal proceeds we are abandoning both. Private patients will migrate to private hospitals and public hospitals will lose out on the millions of euro in funding they currently collect from privately insured patients. No one wins. As things stand, this proposal is exactly that – a proposal. It requires further thought. The Health Insurance Consultative Forum, recently established by Minister Reilly, is an ideal environment to give this proposal deeper evaluation.
  • 6. The proposal on bed re-designation comes against a wider backdrop of rising bed charges over the past number of years. One way to contain bed charge increases is to allow insurers negotiate bed charges with individual hospitals. Currently, the Minister applies a one- size-fits-all charge. The Minister has publicly called on insurers to control premium increases by negotiating prices with the service providers, whether hospitals or consultants. Allowing insurers negotiate with hospitals empowers us to do this. It is something which Aviva fully supports. The second factor hindering affordability is health insurance competition. We need to do more to make our health insurance market more competitive. To do that, we need radical reform. The Minister for Health and the Minister for Finance – who also has a key role in this area – have given positive indications around reform. Aviva welcomed the decision by the Minister for Health to establish a Health Insurance Consultative Forum to drive this programme. But no Forums are necessary to highlight the one glaring inequity which exists in health insurance today – regulation, or the lack of regulation. Currently, the dominant player in the market, Vhi, with almost 60% of the total market, remains unregulated by the Central Bank of Ireland. The failure to regulate the Vhi perpetuates a situation where Vhi is treated in a different and more favourable manner from its competitors. The result of this lack of regulation is two-fold:  It leaves Vhi in a protected position and impedes the development of a truly competitive health insurance market; and  The Vhi continues to be exempt from the Consumer Protection Code (CPC), imposed by the Central Bank of Ireland and designed to protect consumers. This may leave consumers vulnerable in their dealings with Vhi.
  • 7. I mentioned the Code because as many of you may know, Aviva, itself, was recently fined by the Central Bank for breaches of this Code. We regret that this breach happened in the first instance. Once aware of it, we took immediate steps to rectify these breaches, a fact which was acknowledged by the CBI in reaching a settlement. I make no bones about it. Aviva Health implemented the Code in full but failed to abide to the letter of the Code. Fortunately, no customers were disadvantaged by the breach, nonetheless, we recognise that the Code requires complete adherence. Given Ireland’s financial recent history, it is understandable that the CBI takes the need for regulation seriously. The result of our breach was that we were slapped on the wrist to the tune of almost €250,000. Believe me it is a painful slap for any company. We accept the Central Bank’s rationale. But if that rationale is being applied to some and not all, then the whole system is undermined. All players in the market must be subject to a level playing field and a regulatory regime which treats all equally. With the Vhi outside of regulation, this is not currently the case. It is hindering a truly competitive market. To be fair, Vhi is working to streamline its operations and its annual results published yesterday reflect this. However, in terms of its regulation the power to act lies with Ministers for Finance and Health. In the short term, the need for the Government to increase the Vhi’s capital solvency margins and the costs to the Exchequer of doing so, impede regulation. However, Ireland’s current budgetary constraints cannot be used as an excuse.
  • 8. Aviva believes that the Government and Central Bank can decouple the solvency issue from CPC regulation by seeking to resolve the solvency issue in the medium term and applying the Consumer Protection Code to Vhi in the immediate term. In conclusion, let me leave you with some positive comments. In my experience, properly run private health insurers are extremely adept at managing costs. This feeds directly into the wider healthcare system. Effective cost control with a focus on primary care will help make healthcare more accessible and affordable for all. Private health insurers are also often first adopters of new technology and medical innovations. For example, drawing from Aviva’s own experiences, we were the first, and only, health insurer to cover our customers with breast cancer, for Oncotype DX testing, on all health insurance plans. This breakthrough test is now also being provided by the State. It has the potential to transform clinical cancer care and could help women diagnosed with breast cancer avoid unnecessary chemotherapy, saving patients from unnecessary treatment and the government unnecessary costs. Similarly, Aviva Health was also the first to offer discounted cervical cancer vaccinations under our health plans. This initiative was followed by a universal vaccination programme. I am convinced that private health insurers have the capacity to continue to be first responders to healthcare innovations which deliver cost savings and benefits for patients. I am convinced that private health insurers have a vital role to play in the reform agenda. And I am convinced more than ever that our input will result in better policy decisions, better outcomes for patients and a better, more viable healthcare system. Thank you.